Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2014-05-19 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于子公司和泽生物科技有限公司与贵州省红十字会医院有限公司投资建设贵州省红十字会细胞组织库的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding an investment by the company and its subsidiary in a new joint venture company. It details the investment amount, the parties involved, the business scope, the board and management structure, and the risks associated with the investment. There are no financial statements, quarterly or annual results, or audit information. The document is a formal announcement of a corporate investment transaction rather than a financial report or regulatory filing about financial results or governance changes. It does not fit into categories like Annual Report, Interim Report, or Management Reports. It is also not a Board/Management Information announcement about personnel changes. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a corporate investment transaction that does not fit into more specific categories.
2014-05-19 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring (重大资产重组进展公告). It mentions board meetings, approvals of share issuance and cash payment plans for asset purchase, stock suspension and resumption, due diligence, audit, evaluation, and profit forecast reviews related to the restructuring. It also states that the transaction plan has been finalized and that further board meetings will be held. The document is short (660 characters) and serves as an update on the progress of a major asset restructuring, not the full detailed report or financial statements. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including major asset restructurings. Therefore, the correct classification is CAP with high confidence.
2014-05-15 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is titled as a "重大资产重组进展公告" which translates to "Major Asset Restructuring Progress Announcement." It discusses the progress of a major asset reorganization, including due diligence, audit, evaluation, and profit forecast review. It mentions the company's stock suspension and plans to disclose further progress within 5 trading days. The document is an announcement about the progress of a major asset restructuring, not the actual restructuring report or financial statements. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2014-05-08 Chinese
关于2014年限制性股票激励计划获中国证监会备案无异议的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the approval and filing of a 2014 restricted stock incentive plan with the China Securities Regulatory Commission. It mentions the board meeting approval and the upcoming shareholder meeting to vote on the plan. The document is short (539 characters) and serves as an official announcement of regulatory approval and next steps rather than the full incentive plan details or financial data. It does not contain financial statements or detailed report content. Therefore, it fits best as a Regulatory Filing (RNS) since it is a compliance announcement about a regulatory approval and upcoming shareholder meeting, not a full report or financial disclosure.
2014-05-05 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is titled as a "重大资产重组进展公告" which translates to "Major Asset Restructuring Progress Announcement." It discusses the progress and issues related to a major asset restructuring, including board meeting approvals, stock suspension and resumption, ongoing due diligence, and negotiations. The document is an announcement about the progress of a major asset restructuring, not the actual restructuring report or financial statements. It fits the category of Capital/Financing Update (CAP) as it relates to updates on company fundraising and capital structure changes due to the asset reorganization. The document length is short and it is clearly an announcement of progress rather than a full report, so it is not an Annual Report or M&A filing. Therefore, the correct classification is CAP with high confidence.
2014-04-29 Chinese
关于举行2013年年度报告业绩说明会公告
AGM Information Classification · 95% confidence The document is an announcement about holding a performance explanation meeting related to the 2013 annual report. It mentions that the 2013 annual report was already published on April 18, 2014, and the meeting is scheduled for May 6, 2014. The document is short (560 characters) and serves to notify investors about the upcoming meeting rather than containing the annual report itself or detailed financial data. Therefore, it is an announcement related to the annual report, specifically an AGM Information type or a report publication announcement. However, since it is about a performance explanation meeting (业绩说明会), which is typically a presentation or meeting related to the annual report, the best fit is AGM Information (AGM-R).
2014-04-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.